Health ❯Obesity

Obesity Treatment

Fat Conversion Semaglutide Medications Zepbound Medicare Coverage Clinical Trials Hormonal Mechanisms

Diabetes and Obesity Drugs Found to Protect Kidney Health

New research highlights significant kidney and heart benefits of GLP-1 receptor agonists for patients with or without diabetes.

Semaglutide Shows Promising Results in Reducing Knee Arthritis Pain in Obese Patients

Scientists Convert White Fat Cells to Calorie-Burning Beige Fat

Medicare's Prohibition on New Obesity Drugs Under Fire